Induced pluripotent stem cells (iPSCs) have been utilized to study physiological development and also the pathogenesis of heart diseases. iPS-derived cardiomyocytes and engineered cardiac tissues provide a promising capacity for investigating cardiac development and disease modeling. In addition to protocols for cardiac differentiation and 3D cardiac tissue construction, the establishment of protocols for the comprehensive evaluation of the physiological and/or pathophysiological properties for the iPS-derived cells/tissues are indispensable.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/978-1-0716-1484-6_10 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!